Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Investment Chat Board Lawsuits -- Ignore unavailable to you. Want to Upgrade?

To: Glenn Petersen who wrote (3295)	6/12/2002 1:31:16 PM
From: Glenn Petersen	Read Replies (1) \| Respond to of 12465

The retraction: biz.yahoo.com Monday June 10, 4:45 pm Eastern Time Press Release SOURCE: Internet Wire RETRACTION: CEL-SCI Corporation And TAKEDA CHEMICAL INDUSTRIES, LTD. Enter Worldwide Collaboration To Develop And Commercialize MULTIKLINE (TM) Agreement For A Potential Cancer Cure LOS ANGELES, CA--(INTERNET WIRE)--Jun 10, 2002 -- On June 10, 2002 at 08:30 EST, a press release entitled "CEL-SCI Corporation and TAKEDA CHEMICAL INDUSTRIES, LTD. Enter Worldwide Collaboration to Develop and Commercialize MULTIKLINE (TM) Agreement for a Potential Cancer Cure," which falsely identified CEL-SCI Corporation (AMEX:CVM - news) and Takeda Chemical Industries, Ltd. as the source, was distributed through Internet Wire. CEL-SCI Corporation states that it did not authorize the release and that the contents of the release are false. Internet Wire regrets the error and is investigating the matter. -------------------------------------------------------------------------------- Contact: Contact: Amy Orebaugh Company: Internet Wire, Inc. Title: Public Relations Manager Voice: 310-846-3712 Email: aorebaugh@internetwire.com